Gardasil for guys

Correlates of intent to be vaccinated

Richard A. Crosby, Ralph DiClemente, Laura F. Salazar, Rachel Nash, Sinead Younge

Research output: Contribution to journalArticle

Abstract

Background: The lack of post Food and Drug Administration (FDA)-approval acceptance studies among males aged 18-26 years is problematic relative to the design of human papillomavirus (HPV) vaccine promotion programs designed to target males. Accordingly this study identified correlates of intention to receive the HPV vaccine among young men. Methods: Young men (n= 150) were recruited from two university campuses in the southern United States. Men completed an audio computer-assisted self administered interview assessing their beliefs, attitudes, and intent to receive the vaccine, newly approved for males. Bivariate associations between various measures and men's intent to be vaccinated in the next 12 months were assessed using t-tests. Measures achieving bivariate significance were entered into a regression model. Results: In the regression model, those reporting oral-genital sex were more likely to have positive intent (β = 0.32, t= 4.20, P= 0.0001). Those classified as having a relatively higher perceived susceptibility to HPV were more likely to have positive intent (β = 0.19, t= 2.53, P= 0.013). Finally, intent was associated with agreement/disagreement to the statement that " the HPV vaccine is so new that I should wait awhile before deciding about getting vaccinated" (β = 0.19, t= 2.49, P= 0.014). Those not agreeing were more likely to have positive intent. Conclusion: Young men who have had oral-genital sex and those with greater perceptions of susceptibility to HPV may have greater intent to receive the HPV vaccine. A barrier reducing their intention for vaccination may be the relatively new introduction of this vaccine to the male population.

Original languageEnglish (US)
Pages (from-to)119-125
Number of pages7
JournalJournal of Men's Health
Volume8
Issue number2
DOIs
StatePublished - May 1 2011

Fingerprint

Papillomavirus Vaccines
Sexual Behavior
Vaccines
Drug Approval
Ego
United States Food and Drug Administration
Vaccination
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Interviews
Population

Keywords

  • Cervical cancer
  • Human papillomavirus
  • Prevention
  • Sexual behavior
  • Young males

ASJC Scopus subject areas

  • Urology

Cite this

Gardasil for guys : Correlates of intent to be vaccinated. / Crosby, Richard A.; DiClemente, Ralph; Salazar, Laura F.; Nash, Rachel; Younge, Sinead.

In: Journal of Men's Health, Vol. 8, No. 2, 01.05.2011, p. 119-125.

Research output: Contribution to journalArticle

Crosby, Richard A. ; DiClemente, Ralph ; Salazar, Laura F. ; Nash, Rachel ; Younge, Sinead. / Gardasil for guys : Correlates of intent to be vaccinated. In: Journal of Men's Health. 2011 ; Vol. 8, No. 2. pp. 119-125.
@article{de841f5f206a4c709cf1f15f059f65c2,
title = "Gardasil for guys: Correlates of intent to be vaccinated",
abstract = "Background: The lack of post Food and Drug Administration (FDA)-approval acceptance studies among males aged 18-26 years is problematic relative to the design of human papillomavirus (HPV) vaccine promotion programs designed to target males. Accordingly this study identified correlates of intention to receive the HPV vaccine among young men. Methods: Young men (n= 150) were recruited from two university campuses in the southern United States. Men completed an audio computer-assisted self administered interview assessing their beliefs, attitudes, and intent to receive the vaccine, newly approved for males. Bivariate associations between various measures and men's intent to be vaccinated in the next 12 months were assessed using t-tests. Measures achieving bivariate significance were entered into a regression model. Results: In the regression model, those reporting oral-genital sex were more likely to have positive intent (β = 0.32, t= 4.20, P= 0.0001). Those classified as having a relatively higher perceived susceptibility to HPV were more likely to have positive intent (β = 0.19, t= 2.53, P= 0.013). Finally, intent was associated with agreement/disagreement to the statement that {"} the HPV vaccine is so new that I should wait awhile before deciding about getting vaccinated{"} (β = 0.19, t= 2.49, P= 0.014). Those not agreeing were more likely to have positive intent. Conclusion: Young men who have had oral-genital sex and those with greater perceptions of susceptibility to HPV may have greater intent to receive the HPV vaccine. A barrier reducing their intention for vaccination may be the relatively new introduction of this vaccine to the male population.",
keywords = "Cervical cancer, Human papillomavirus, Prevention, Sexual behavior, Young males",
author = "Crosby, {Richard A.} and Ralph DiClemente and Salazar, {Laura F.} and Rachel Nash and Sinead Younge",
year = "2011",
month = "5",
day = "1",
doi = "10.1016/j.jomh.2011.03.001",
language = "English (US)",
volume = "8",
pages = "119--125",
journal = "Journal of Men's Health and Gender",
issn = "1875-6867",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Gardasil for guys

T2 - Correlates of intent to be vaccinated

AU - Crosby, Richard A.

AU - DiClemente, Ralph

AU - Salazar, Laura F.

AU - Nash, Rachel

AU - Younge, Sinead

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Background: The lack of post Food and Drug Administration (FDA)-approval acceptance studies among males aged 18-26 years is problematic relative to the design of human papillomavirus (HPV) vaccine promotion programs designed to target males. Accordingly this study identified correlates of intention to receive the HPV vaccine among young men. Methods: Young men (n= 150) were recruited from two university campuses in the southern United States. Men completed an audio computer-assisted self administered interview assessing their beliefs, attitudes, and intent to receive the vaccine, newly approved for males. Bivariate associations between various measures and men's intent to be vaccinated in the next 12 months were assessed using t-tests. Measures achieving bivariate significance were entered into a regression model. Results: In the regression model, those reporting oral-genital sex were more likely to have positive intent (β = 0.32, t= 4.20, P= 0.0001). Those classified as having a relatively higher perceived susceptibility to HPV were more likely to have positive intent (β = 0.19, t= 2.53, P= 0.013). Finally, intent was associated with agreement/disagreement to the statement that " the HPV vaccine is so new that I should wait awhile before deciding about getting vaccinated" (β = 0.19, t= 2.49, P= 0.014). Those not agreeing were more likely to have positive intent. Conclusion: Young men who have had oral-genital sex and those with greater perceptions of susceptibility to HPV may have greater intent to receive the HPV vaccine. A barrier reducing their intention for vaccination may be the relatively new introduction of this vaccine to the male population.

AB - Background: The lack of post Food and Drug Administration (FDA)-approval acceptance studies among males aged 18-26 years is problematic relative to the design of human papillomavirus (HPV) vaccine promotion programs designed to target males. Accordingly this study identified correlates of intention to receive the HPV vaccine among young men. Methods: Young men (n= 150) were recruited from two university campuses in the southern United States. Men completed an audio computer-assisted self administered interview assessing their beliefs, attitudes, and intent to receive the vaccine, newly approved for males. Bivariate associations between various measures and men's intent to be vaccinated in the next 12 months were assessed using t-tests. Measures achieving bivariate significance were entered into a regression model. Results: In the regression model, those reporting oral-genital sex were more likely to have positive intent (β = 0.32, t= 4.20, P= 0.0001). Those classified as having a relatively higher perceived susceptibility to HPV were more likely to have positive intent (β = 0.19, t= 2.53, P= 0.013). Finally, intent was associated with agreement/disagreement to the statement that " the HPV vaccine is so new that I should wait awhile before deciding about getting vaccinated" (β = 0.19, t= 2.49, P= 0.014). Those not agreeing were more likely to have positive intent. Conclusion: Young men who have had oral-genital sex and those with greater perceptions of susceptibility to HPV may have greater intent to receive the HPV vaccine. A barrier reducing their intention for vaccination may be the relatively new introduction of this vaccine to the male population.

KW - Cervical cancer

KW - Human papillomavirus

KW - Prevention

KW - Sexual behavior

KW - Young males

UR - http://www.scopus.com/inward/record.url?scp=79956354477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956354477&partnerID=8YFLogxK

U2 - 10.1016/j.jomh.2011.03.001

DO - 10.1016/j.jomh.2011.03.001

M3 - Article

VL - 8

SP - 119

EP - 125

JO - Journal of Men's Health and Gender

JF - Journal of Men's Health and Gender

SN - 1875-6867

IS - 2

ER -